the drug problem: balancing pricing, affordability and ... - the drug problem... · promise and...
Post on 27-May-2018
213 Views
Preview:
TRANSCRIPT
The drug problem: balancing pricing, affordability and innovation
Peter B. Bach, MD, MAPPMemorial Sloan Kettering Cancer Center
bachp@mskcc.org@peterbachmd
RecentProjects
• Indication Specific Pricing
• Medicare Part B Payment
Pilot
• Tracking of Recent Pricing
Trends
• R&D Premiums
• Outcomes‐based contracting
vs value‐based pricing
• Gilead Buy‐Out
www.drugpricinglab.org
RecentProjects
• Gilead Buy‐Out
• Copay assistance
• Louisiana budget allocator
• DPL Policy Tracker
www.drugpricinglab.org
Erin Trish et al. Health Aff 2016;35:1564-1571©2016 by Project HOPE - The People-to-People Health Foundation, Inc.
Spendingblowingupactuarialstructuresofinsuranceproducts
http://blogs.wsj.com/washwire/2016/06/30/the-next-big-debate-in-health-care/?utm_content=bufferbcd65&utm_medium=social&utm_source=plus.google.com&utm_campaign=buffer
Greaterexposuretopricesiscoming
% patients exposed to >1/3 of drug’s actual cost:
2014: 37% of plans
2016: 63% of plans
Large Employers Exchange Plans
top related